Buy this Article for $5.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.


* Albiglutide (Tanzeum), a glucagon-like peptide-1 agonist, has been approved by the FDA for the treatment of type 2 diabetes.


* Patients who have a personal or family history of medullary thyroid carcinoma shouldn't be prescribed albiglutide.